Rhythm Biosciences Limited (ASX:RHY)
0.0900
-0.0010 (-1.10%)
Sep 26, 2025, 4:10 PM AEST
Rhythm Biosciences Revenue
In the fiscal year ending June 30, 2025, Rhythm Biosciences had annual revenue of 3.19M AUD with 88.85% growth. Rhythm Biosciences had revenue of 25.63K in the half year ending June 30, 2025, a decrease of -93.16%.
Revenue
3.19M
Revenue Growth
+88.85%
P/S Ratio
9.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.05M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 3.19M | 1.50M | 88.85% |
Jun 30, 2024 | 1.69M | -1.41M | -45.41% |
Jun 30, 2023 | 3.10M | 668.44K | 27.54% |
Jun 30, 2022 | 2.43M | 1.32M | 118.98% |
Jun 30, 2021 | 1.11M | 1.01M | 1,008.51% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.79B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.06B |
Mesoblast | 26.23M |